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Abstract
Background: Clinical chemical blood analysis including plasma electrolytes is routinely carried out
for the diagnosis of various organ diseases. Phenotype-driven N-ethyl-N-nitrosourea (ENU) mouse
mutagenesis projects used plasma electrolytes as parameters for the generation of novel animal
models for human diseases.
Methods: Here, we retrospectively evaluated the use of the plasma electrolytes calcium, chloride,
inorganic phosphorus, potassium and sodium in the Munich ENU mouse mutagenesis project
where clinical chemical blood analysis was carried out on more than 20,000 G1 and G3 offspring
of chemically mutagenized inbred C3H mice to detect dominant and recessive mutations leading to
deviations in various plasma parameter levels.
Results: We identified a small number of animals consistently exhibiting altered plasma electrolyte
values. Transmission of the phenotypic deviations to the subsequent generations led to the
successful establishment of mutant lines for the parameters calcium and potassium. Published data
from other phenotype-driven ENU projects also included only a small number of mutant lines
which were generated according to altered plasma electrolyte levels.
Conclusion: Thus, use of plasma electrolytes detected few mouse mutants in ENU projects
compared to other clinical chemical blood parameters.
Background
Clinical chemical plasma analyses are often used in the
medical examination of patients for the diagnosis of the
involvement of various organs as well as for the evalua-
tion of therapeutic strategies in multifactorial and poly-
genic human diseases. Electrolytes including calcium,
chloride, inorganic phosphorus, potassium and sodium
are routine parameters in these analyses. The diagnostic
impact of plasma electrolyte values includes the general
maintenance of osmotic pressure, water distribution and
acid-base equilibrium (Na, Cl, K) as well as tissue-specific
metabolism and organ function, especially of bone and
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distribution of the electrolytes reveals that K is the chief
intracellular cation, therefore, measured plasma K values
are increased in the case of hemolysis or cellular stress like
muscle trauma (Table 1). Together with the results of
other diagnostic parameters, plasma electrolytes contrib-
ute to the identification of the impaired organ function(s)
[1,2].
Biomedical research is done with mice as the animal mod-
els of choice and includes the search for alleles predispos-
ing for or protecting against specific diseases. A strategy for
the genome-wide generation and search of novel disease-
related alleles consists of the random chemical mutagene-
sis of a large number of animals followed by systematic
screening for clinically relevant disease phenotypes. The
most widely used mutagen is N-ethyl-N-nitrosourea
(ENU) which is mutagenic for premeiotic spermatogonial
stem cells. This allows the production of a large number
of randomly mutant offspring from treated males. ENU
predominantly induces point mutations which results in
allelic series for the functional analysis of genes [3]. Dur-
ing the last years, ENU mouse mutagenesis projects were
established for the systematic, genome-wide, large-scale
production and analysis of mouse mutants as model sys-
tems for inherited human diseases. They used appropriate
routine procedures allowing the screening of large num-
bers of mice for a broad spectrum of parameters [4,5].
Mutant lines were established for various phenotypic
parameters. ENU-induced mice with the causative muta-
tion already identified are successfully used in different
areas of biomedical research ([6,7] and refs. therein).
In the Munich ENU mouse mutagenesis project, a stand-
ardized screening profile of clinical chemical blood
parameters was established for the analysis of offspring of
mutagenized inbred C3H mice in order to detect pheno-
typic variants with defects of diverse organ systems and/or
changes in metabolic pathways [8,9]. Here we retrospec-
tively evaluated the generation of mutant lines exhibiting
deviations from the physiological range of the plasma
electrolyte values of Ca, Cl, K, Na and P.
Methods
Mutagenesis and breeding of mice
The experiments were carried out on the inbred C3HeB/
FeJ (C3H) genetic background as described [4,10]. Ten-
week-old male mice (= generation G0) were injected
intraperitoneally with ENU (three doses of 90 mg/kg in
weekly intervals).
The screen for dominant mutations was performed on G1
animals which were derived from the mating of the muta-
genized G0 males to wild-type C3H females. Inheritance
of the observed abnormal phenotype was tested on G2
mice which were derived from the mating of the affected
G1 mouse exhibiting the altered phenotype and wild-type
mice.
The screen for recessive mutations was carried out on G3
mice produced in a two-step breeding scheme from G1
mice. G1 males, which were excluded to exhibit dominant
mutations by phenotypic analysis, were mated to wild-
type females for the production of G2 animals. Subse-
quently, 6–8 G2 females were backcrossed to the G1 male
to produce the G3 mice of the pedigree. The analysis of the
inheritance of an observed abnormal phenotype in G3
mice was done on G5 mice. Therefore, the affected G3
mouse presumably harboring a homozygous recessive
mutation was mated to a wild-type mouse for the produc-
tion of the presumably heterozygous mutant G4 mice
with an inconspicuous phenotype. Subsequently, the G5
Table 1: Plasma electrolytes examined in the Munich ENU mouse mutagenesis project
Electrolyte Intracellular vs. extracellular level Diagnostic impact Olympus kit/ISE Range (mmol/l)a
Ca Very low Parathyroidea, bone, kidney OSR6176 1–4
Cl Low; major anion in plasma Osmotic regulation, acid-base status, kidney Ion-selective electrode 50–200
K Major cation, low in plasma K+ transport system, acid-base status, kidney Ion-selective electrode 1–10
Na Low; major cation in plasma Osmotic regulation, kidney Ion-selective electrode 50–200
P, inorganic Higher in cells P uptake, bone, kidney OSR6122 0.3–6.4
a Linear measurement range (mmol/l) for the Olympus AU400 autoanalyzer (Olympus, Hamburg, Germany) and the reagents for human samples 
according to the manufacturer.Page 2 of 7
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for the abnormal phenotype. Alternatively, G5 mice
derived from the backcross of a G4 mouse to the affected
G3 animal were examined.
After the identification of the causative mutation, the pro-
visional names of the established lines will be replaced
according to the official nomenclature. Mouse husbandry
was done under a continuously controlled specific patho-
gen-free (SPF) hygiene standard according to the FELASA
recommendations http://www.felasa.eu[11]. All animal
experiments were carried out under the approval of the
responsible animal welfare authority (Regierung von
Oberbayern).
Clinical chemical analysis
Plasma from three-month-old G1 and G3 mice was ana-
lyzed for the electrolytes Ca, Cl, K, Na and P. In the cases
where altered values below or above the physiologic range
appeared, the mice were retested after three weeks. Blood
samples were obtained by puncture of the retroorbital
sinus under general short-term anesthesia. Plasma from
Li-heparin treated blood was first analyzed for the electro-
lyte values using the Roche Hitachi 717 autoanalyzer
(Roche, Mannheim, Germany) and the reagents for
human samples (Roche), and in the second part of the
project with the Olympus AU400 autoanalyzer (Olym-
pus, Hamburg, Germany) and the reagents for human
samples (Olympus) (Table 1). Calibration and quality
control were performed according to the manufacturer's
protocols.
In addition, the clinical chemical screen of plasma sam-
ples included substrates (cholesterol, creatinine, glucose,
total protein, triglycerides, urea, uric acid) and enzyme
activities (alanine aminotransferase, aspartate ami-
notransferase, alkaline phosphatase, -amylase, creatine
kinase) [12].
Statistical analysis
The statistical analysis of the data was carried out using
the software program Microsoft Excel 2000 (Microsoft,
Redmond, WA). Values are presented as medians, and
95% and 90% ranges unless stated otherwise. Statistical
significance (defined as p < 0.05) was evaluated using the
2-test.
Results and discussion
Physiologic plasma electrolyte values in C3H mice
In the Munich ENU mouse mutagenesis project, the val-
ues for the plasma electrolytes Ca, Cl, K, Na and P were
first determined in about 200 male and 200 female three-
month-old wild-type C3H mice [13] and the 95% range of
the values was defined to be physiologic [2]. According to
the chosen physiologic range, abnormally low and high
values were determined in the G1 and G3 offspring of
ENU-mutagenized mice. The chosen physiologic range
must allow to phenotypically detect animals with herita-
ble defects leading to altered plasma parameter levels. On
the other hand, it must exclude smaller variations from
the mean level which are not suitable for breeding a
mutant line over several generations according to the phe-
notypic variations. As the Munich ENU project was carried
out in two different mouse facilities over a time period of
many years, we re-evaluated the cut-off levels in retrospect
for the present study. Plasma values of 15,700 to 16,600
G1 and G3 offspring of ENU-mutagenized mice were
included for each electrolyte. Less than 1% of the G1 and
G3 mice were expected to be primarily altered by ENU-
induced mutations for a given blood parameter. Thus, the
95% range of the values determined in the large resource
of animals should also comply with the successful detec-
tion and breeding of mutant animals with altered plasma
electrolyte values. The analysis was done separately for the
two time periods where different measurement equip-
ments were used (Table 2). Calculation of the plasma elec-
trolyte values for both mouse facilities separately and per
year confirmed the results for both measurement equip-
ments (data not shown). Comparison of the data of both
equipments showed similar values for Ca, higher values
for Cl, K and Na, and lower values for P with the Olympus
equipment. Considerable sex-specific differences were
seen for K, where males showed higher physiologic values
(Table 2). Physiologic ranges of plasma electrolytes have
been published from other projects [2]http://www.inter
phenome.org. Our data measured with the Olympus
equipment are in accordance with published results
which were determined with the same measurement
equipment for three-month-old C3HeB/FeJ mice except
of plasma Na where our data from the Roche equipment
better fitted to the published results [14]http://
www.europhenome.eu.
Subsequently, deviations in plasma electrolyte values
were defined in our analysis for mice showing values
below or above the limits of the 95% range in two meas-
urements of a three-week interval.
ENU-induced phenotypic variants showing altered plasma 
electrolyte values
In the Munich ENU mouse mutagenesis project, more
than 20,000 three-month-old G1 and G3 offspring of
ENU-treated mice were screened for dominant and reces-
sive mutations for various blood parameters. Plasma val-
ues of Ca, Cl, K, Na and P were detected in 15,700 to
16,600 G1 and G3 offspring. Table 2 shows the exact
numbers of mice analyzed for each electrolyte. The exam-
ined offspring included 11,700 G1 mice and 6,300 G3
mice. For the five plasma electrolytes, 56 animals were
identified as phenotypic variants showing decreased orPage 3 of 7
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week interval (Ca low: 3 animals from the dominant
screen/1 animal from the recessive screen, Ca high: 2/7, Cl
low: 3/3, Cl high: 1/1, K low: -/-, K high: 7/12, Na low: 6/
4, Na high: 2/1, P low: 3/6, P high: -/-). Six G1/G3 pheno-
typic variants showed deviations in two plasma electrolyte
levels (three G1 and one G3 phenotypic variants for Cl
and Na, two G3 phenotypic variants for Ca and Na). The
24 G1 phenotypic variants from the dominant screen of
11,700 G1 mice were offspring of 23 ENU-mutagenized
G0 males. One G0 male produced two G1 phenotypic var-
iants, one for Cl and Na, and the other for K. The 32 G3
phenotypic variants from the recessive screen of 6,300 G3
mice were offspring of 21 G1 males which were derived
from 21 different ENU-mutagenized G0 males. Seven G1
males produced in total 18 G3 phenotypic variants (four
G3 siblings with increased Ca, three G3 siblings with
decreased P, three G3 siblings with altered Ca or P, three
pedigrees each with two G3 siblings with increased K, and
two G3 siblings with descreased Cl). Appearance of
altered plasma electrolyte levels in several offspring of an
ENU-mutagenized mouse may indicate a heritable muta-
tion as cause for the affected phenotype allowing the
establishment of a mutant line. In these cases, the pheno-
typic variants are presumed to harbor the identical causa-
tive mutation within the affected pedigree. However, only
one of these affected pedigrees was analyzed for the trans-
mission of the abnormal phenotype to the offspring
resulting in mutant line KAL007 (see below).
For all five electrolytes, more than 80,000 measurements
were taken. Having chosen the 95% range as physiologic
data range, 100 animals of a wild-type population are cal-
culated to show values below/above the cut-off level in
two subsequent measurements by chance. This is twice
the number of phenotypic variants identified with the
plasma electrolytes as examination parameters in our
ENU project. Plasma substrates and plasma enzyme activ-
Table 2: Retrospective analysis of the physiologic range of plasma electrolytes (mmol/l) in three-month-old C3H mice of the Munich 
ENU project
Roche measurement equipmenta Olympus measurement equipmenta
Electrolyte Sex nb Median 95% Rangec 90% Range nb Median 95% Rangec 90% Range
Ca m 6142 2.2 1.9–2.5 2.0–2.5 3945 2.2 1.8–2.4 2.0–2.4
Ca f 4411 2.3 2.0–2.6 2.1–2.5 2152 2.2 2.0–2.5 2.0–2.4
Cl m 6145 108 88–122 92–118 3345 115 104–126 106–124
Cl f 4418 108 88–124 92–122 1836 115 102–125 106–123
K m 6145 4.7 3.8–5.8 3.9–5.6 3345 5.0 4.0–6.0 4.2–5.8
K f 4420 4.3 3.5–5.5 3.7–5.2 1836 4.6 3.8–5.8 4.0–5.6
Na m 6146 152 138–164 140–162 3345 158 144–172 146–168
Na f 4419 152 138–166 142–162 1836 156 144–172 146–168
P m 6145 2.1 1.5–2.9 1.6–2.8 3923 1.8 1.4–2.6 1.4–2.4
P f 4416 2.3 1.6–3.0 1.7–2.9 2151 2.0 1.4–2.6 1.4–2.6
m, male; f, female.
a Plasma electrolyte levels were analyzed using the Roche Hitachi 717 autoanalyzer and the reagents for human samples, and subsequently the 
Olympus AU400 autoanalyzer and the reagents for human samples.
b G1 and G3 offspring of ENU-treated mice for the dominant and recessive screen. About 60% of the analyzed mice were males.
c Phenotypic variants were defined by two measurements of a three-week time period showing values below/above the lower/upper limit of the 
95% range of the respective parameter.Page 4 of 7
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of phenotypic variants in the same resource of mice. 44
phenotypic variants were observed with increased plasma
urea levels, more than 150 phenotypic variants showing
hyper- or hypocholesterolemia, and more than 300 phe-
notypic variants were observed for the five plasma enzyme
activities alanine aminotransferase, aspartate aminotrans-
ferase, alkaline phosphatase, -amylase and creatine
kinase ([15] and refs. therein).
Establishment of mutant lines showing altered plasma 
electrolyte values
Phenotypic variants were tested for the inheritance of the
deviations in plasma electrolyte values during the ENU
project. This was analyzed on G2 offspring from the mat-
ing of G1 phenotypic variants to wild-type mice in the
screen for dominant mutations, and on G4 × G3 back-
cross offspring after breeding G3 phenotypic variants to
wild-type mice in the screen for recessive mutations.
Sperm was cryo-preserved from male phenotypic variants
which were not mated because of limitations of the breed-
ing capacity wherever it was possible. A heritable altered
plasma electrolyte level was diagnosed when offspring of
the phenotypic variants showed values below/above the
cut-off level in two measurements of a three-week inter-
val.
During the ENU project, only few phenotypic variants
with clearly altered plasma electrolyte levels were
detected. Therefore, phenotypic analysis of the offspring
was carried out only for six of the retrospectively identi-
fied G1/G3 phenotypic variants. One phenotypic G1 var-
iant and one phenotypic G3 variant gave rise to no
phenotypic mutant offspring. The other four phenotypic
variants showed the inheritance of altered plasma electro-
lyte values to the offspring which included one pheno-
typic G1 variant showing decreased plasma Ca (line
CA001) and three G3 animals showing increased K (lines
KAL003, KAL004, KAL007). No sperm was cryo-preserved
from line CA001. In addition, a mutant line showing
increased K values (line KAL006) was produced by using
a male G1 animal with the two measurements (5.8 and
5.7 mmol/l) below the cut-off level (Table 3). Establish-
ment of further mutant lines with increased K values was
not successful by breeding three additional G3 mice
showing plasma K levels below the high cut-off level. In
view of a putative renal cause for the increased plasma K
values, the founder mice of all lines showed plasma urea
levels within the normal range.
The frequency of the altered plasma electrolyte values in
the five mutant lines was expected to be 50% after mating
heterozygous mutants to wild-type animals in the lines
with a dominant mutation and by breeding homozygous
mutants to heterozygous mutant mice in the lines with a
recessive mutation. The mutant phenotype was detected
in more than half of the expected cases in all five lines.
This indicated the monogenetic cause of the abnormal
phenotype. In addition, this facilitates the effective subse-
quent phenotypic and molecular genetic analyses. In the
lines with higher numbers of tested offspring, the num-
bers of animals exhibiting plasma K above the cut-off level
were significantly (2-test, p < 0.001) higher than the
expected 2.5% of the C3H mouse population when con-
sidering the 95% range as physiologic data range (Table
3).
Our previously published screen for altered plasma
parameter levels resulted in the establishment of ENU-
induced mutant lines showing changes of substrate (cho-
lesterol, glucose, urea) and enzyme activity levels ([15]
and refs. therein). In these ENU-induced mutant lines,
there was a tendency of increased frequency of the altered
phenotype with increasing age of the mice. Thus, the fre-
quency of the mutant phenotypes may be underestimated
in the present study as the mice were investigated at the
age of three months. In addition, further in-depth analysis
of our ENU-induced mutant lines often revealed higher
frequencies of the altered phenotypes than observed in
the long-term large-scale phenotyping project with the
inherent impossibility of carrying out complete standard-
ization [16]. The plasma electrolyte screen may be
improved by analyzing the animals more frequently and/
or at a higher age.
Mutant lines showing plasma electrolyte deviations 
derived from other phenotype-driven ENU projects
Major centers performing phenotype-driven ENU muta-
genesis-based projects used clinical chemical screens
including plasma electrolytes as examination parameters
for the generation of novel mutant mouse models [17].
Ca, Cl, K, Na and P were used in the CMHD ENU project
http://www.cmhd.ca/enu_mutagenesis/index.html, in
the MRC ENU project [5,18] as well as in the RIKEN ENU
project http://www.brc.riken.jp/lab/gsc/mouse. The ENU
projects used different genetic backgrounds: C57BL/6J ×
C3H http://www.cmhd.ca/enu_mutagenesis/index.html,
BALB/c × C3H [18], and C57BL/6J × DBA/2J or C57BL/6J
× C3H http://www.brc.riken.jp/lab/gsc/mouse.
Line 105-8-1 was described to show low plasma Ca values
with low penetrance in a dominant mode of inheritance
http://www.cmhd.ca/enu_mutagenesis/index.html. Line
EM:02158 (GENA383) showed high plasma Cl and Na
values in a dominant mode of inheritance [18]http://
www.emmanet.org/mutant_types.php. In addition, line
EM:02163 (Candy5) was described to show hyperglyc-
emia and high plasma P values http://www.emmanet.org/
mutant_types.php, line MUTN/823.12.c (GENA/341)
showed low plasma P and low plasma alkaline phos-Page 5 of 7
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plasma high-density lipoprotein cholesterol and low
plasma Na http://www.har.mrc.ac.uk/mousebook. Link-
age analysis for the determination of the chromosomal
site of the causative mutation was not yet described for
any line. In the RIKEN ENU project, no mutant lines were
published using Ca, Cl, K, Na and P as primary examina-
tion parameters in the clinical chemical analysis. How-
ever, the subsequent plasma electrolyte analysis in
phenotypic mutants which have been recognized in other
screens of the ENU project (e.g. using substrates and
enzyme activities of the clinical chemical screen, blood
pressure, behavior, dysmorphology) revealed deviations
in the mutant mice http://www.brc.riken.jp/lab/gsc/
mouse.
Search for defined phenotypes in published chemically
induced (ENU) mutants (as of 18.02.2009) of the "phe-
notypes and alleles" database in the Mouse Genome
Informatics website http://www.informatics.jax.org/
searches/allele_form.shtml revealed 1947 alleles and
1606 genes/markers. Among them, 202 alleles and 172
genes/markers were described with phenotypes influenc-
ing "homeostasis/metabolism" and/or "renal/urinary"
pathways, but no additional lines are described which
have been revealed by the primary phenotype of plasma
electrolyte deviations.
Plasma electrolytes are complementary parameters for the
diagnosis of kidney and bone diseases. We recently
described the generation of five ENU-induced mutant
lines as novel kidney disease models according to their
increased plasma urea levels [19]. The phenotypic mutant
founders showed plasma electrolyte levels within the nor-
mal range. However, differences were observed between
phenotypic mutants and wild-type littermate controls for
defined plasma electrolytes in individual lines (unpub-
lished results). Deviations of plasma Ca and P appeared in
ENU-induced mutant lines which were established in dys-
morphology screens for growth retardation and skeletal
abnormalities (e.g. [20-22]). In addition, measurement of
plasma copper levels as examination parameter was suc-
cessfully carried out to generate novel ENU-induced
mutant lines for the analysis of specific functional path-
ways http://www.informatics.jax.org; http://
www.brc.riken.jp/lab/gsc/mouse.
In contrast to the low numbers of phenotypic variants by
using plasma electrolytes, the clinical chemical screens
carried out for the generation of novel mutant mouse
models in ENU projects were successful with plasma sub-
strates (e.g. cholesterol, glucose, urea) and plasma
enzyme activities as examination parameters ([15] and
refs. therein) [18]http://www.har.mrc.ac.uk/mousebook;
http://www.brc.riken.jp/lab/gsc/mouse.
Table 3: Mutant lines showing deviations of plasma electrolyte values derived from the Munich ENU mouse mutagenesis project
Altered plasma electrolyte valuesb: total (m/f)
Phenotype Mode of inheritance Line Offspring testeda: n (m/f) n % frequency Mean (mmol/l)
Ca low D CA001 6 (2/4) 3 (2/1) 50 (100/25) 1.8/1.8
K high D KAL006 45 (26/19) 13 (10/3) 29 (38/16) 6.1/6.2
K high R KAL003 21 (14/7) 7 (5/2) 33 (36/29) 6.1/5.9
K high R KAL004 10 (5/5) 4 (2/2) 40 (40/40) 6.4/6.6
K high R KAL007 10 (5/5) 4 (3/1) 40 (60/20) 7.5/7.4
10 (6/4) 6 (2/4) 60 (33/100) 7.6/7.3
m/f, males/females; D, dominant mutation; R, recessive mutation.
a Offspring derived from mating heterozygous phenotypic mutants to wild-type mice (screen for dominant mutations) and after breeding 
homozygous mutants to heterozygous mutant mice (screen for recessive mutations). In addition, line KAL007 was successfully bred by mating 
homozygous mutants (second line).
b The frequency of the altered phenotype in the offspring was expected to be 50% after mating heterozygous phenotypic mutants to wild-type mice 
(screen for dominant mutations) and after breeding homozygous mutants to heterozygous mutant mice (screen for recessive mutations). All 
offspring were expected to harbor the altered phenotype after breeding homozygous mutants of line KAL007 (second line). The absolute numbers 
of observed phenotypic mutants are given (n).Page 6 of 7
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In this study, we retrospectively evaluated the use of the
plasma electrolytes Ca, Cl, K, Na and P in the clinical
chemical blood analysis of the Munich ENU mouse muta-
genesis project to detect dominant and recessive muta-
tions leading to deviations in plasma levels. Analysis of
11,700 G1 mice revealed 24 G1 phenotypic variants from
23 ENU-mutagenized G0 males, and analysis of 6,300 G3
mice revealed 32 G3 phenotypic variants from 21 G1
males which were derived from 21 different ENU-muta-
genized G0 males. To date, five mutant lines showing
altered plasma electrolyte levels were produced. The
causes for the increased plasma K levels of the mutant
lines established in our ENU project may be deviations in
the K distribution/metabolism as well as factors leading to
cellular stress e.g. of blood cells. In contrast to other
plasma parameters used and despite a rather wide physio-
logic range of the values of at least some parameters e.g.
Cl, the own results and published data from other pheno-
type-driven ENU projects revealed a small number of mice
with deviations in plasma electrolyte levels. One reason
may be a redundant regulation of plasma electrolyte levels
in essential pathways like the maintenance of osmotic
pressure and acid-base equilibrium leading to the mask-
ing of single mutations by compensatory effects of other
genes. Alternatively, animals with major plasma electro-
lyte deviations may rarely survive until the examination
time point used. Thus, plasma electrolytes as examination
parameters in ENU projects have less impact for the estab-
lishment of novel mutant mouse lines for the functional
kidney and/or bone analysis but are successfully used as
secondary diagnostic parameters for other primary genetic
defects.
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